$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Signal Transduction Network Leading to COX-2 Induction: A Road Map in Search of Cancer Chemopreventives

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.28 no.1, 2005년, pp.1 - 15  

Surh Young-Joon (National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University) ,  Kundu Joydeb Kumar (National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University)

Abstract AI-Helper 아이콘AI-Helper

Cancer is still a major global health concern even after an everlasting strive in conquering this dread disease. Emphasis is now given to chemoprevention to reduce the risk of cancer and also to improve the quality of life among cancer afflicted individuals. Recent progress in molecular biology of c...

주제어

참고문헌 (146)

  1. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., and Takada, Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res., 24, 2783-2840 (2004a) 

  2. Aggarwal, S., Takada, Y., Singh, S., Myers, J. N., and Aggarwal, B. B., Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor- ${\kappa}$ B signaling. Int. J. Cancer, 111, 679-692 (2004b) 

  3. Akarasereenont, P., Mitchell, J. A., Appleton, I., Thiemermann, C., and Vane, J. R., Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. Br. J. Pharmacol., 113, 1522- 1528 (1994) 

  4. Akarasereenont, P. and Thiemermann, C., The induction of cyclo-oxygenase-2 in human pulmonary epithelial cell culture (A549) activated by IL-1 ${\beta}$ is inhibited by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun., 220, 181-185 (1996) 

  5. Allport, V. C., Slater, D. M., Newton, R., and Bennett, P. R., NF- ${\kappa}B$ and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod., 6, 561-565 (2000) 

  6. Alshafie, G. A., Abou-Issa, H. M., Seibert, K., and Harris, R. E., Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase- 2 inhibitor, in a rat mammary tumor model. Oncol. Rep., 7, 1377-1381 (2000) 

  7. Aziz, M., Afaq, F., and Ahmad, N., Prevention of ultraviolet B radiation-damage by resveratrol in mouse skin is mediated via modulation in Survivin. Photochem. Photobiol., in press (2004) 

  8. Baldwin, A. S., Jr., The NF- ${\kappa}$ B and I ${\kappa}$ B proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683 (1996) 

  9. Balkwill, F. and Mantovani, A., Inflammation and cancer: back to Virchow? Lancet, 357, 539-545 (2001) 

  10. Banerjee, S., Bueso-Ramos, C., and Aggarwal, B. B., Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factorkappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res., 62, 4945-4954 (2002) 

  11. Bennett, A., The production of prostanoids in human cancers, and their implications for tumor progression. Prog. Lipid Res., 25, 539-542 (1986) 

  12. Bird, A. P. and Wolffe, A. P., Methylation-induced repression-- belts, braces, and chromatin. Cell, 99, 451-454 (1999) 

  13. Bird, T. A., Schooley, K., Dower, S. K., Hagen, H., and Virca, G. D., Activation of nuclear transcription factor NF- ${\kappa}$ B by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem., 272, 32606-32612 (1997) 

  14. Bode, A. M., Ma, W. Y., Surh, Y.-J., and Dong, Z., Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res., 61, 850-853 (2001) 

  15. Bortuzzo, C., Hanif, R., Kashfi, K., Staiano-Coico, L., Shiff, S. J., and Rigas, B., The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim. Biophys. Acta, 1300, 240-246 (1996) 

  16. Caivano, M. and Cohen, P., Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 ${\beta}$ in RAW264 macrophages. J. Immunol., 164, 3018-3025 (2000) 

  17. Callejas, N. A., Fernandez-Martinez, A., Castrillo, A., Bosca, L., and Martin-Sanz, P., Selective inhibitors of cyclooxygenase-2 delay the activation of nuclear factor ${\kappa}$ B and attenuate the expression of inflammatory genes in murine macrophages treated with lipopolysaccharide. Mol. Pharmacol., 63, 671- 677 (2003) 

  18. Canty, T. G., Jr., Boyle, E. M., Jr., Farr, A., Morgan, E. N., Verrier, E. D., and Pohlman, T. H., Oxidative stress induces NF- ${\kappa}$ B nuclear translocation without degradation of I ${\kappa}$ B ${\alpha}$ . Circulation, 100, II361-364 (1999) 

  19. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J., Cyclooxygenase- 2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994 (1999) 

  20. Chang, M. S., Chen, B. C., Yu, M. T., Sheu, J. R., Chen, T. F., and Lin, C. H., Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, EPK, and NF- ${\kappa}$ B, but nop p38 MAPK, pathways. Cell Signal., 17, 299-310 (2005) 

  21. Chen, C. C., Sun, Y. T., Chen, J. J., and Chiu, K. T., TNF-alphainduced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C- ${\gamma}$ 2, protein kinase C- ${\alpha}$ , tyrosine kinase, NF- ${\kappa}$ B-inducing kinase, and I ${\kappa}$ B kinase 1/2 pathway. J. Immunol., 165, 2719-2728 (2000) 

  22. Chen, C. W., Lee, S. T., Wu, W. T., Fu, W. M., Ho, F. M., and Lin, W. W., Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br. J. Pharmacol., 140, 1077-1087 (2003) 

  23. Chun, K.-S., Kang, J.-Y., Kim, O.-H., Kang, H., and Surh, Y.-J., Effects of yakuchinone A and yakuchinone B on the phorbol ester-induced expression of COX-2 and iNOS and activation of NF- ${\kappa}$ B in mouse skin. J. Environ. Pathol. Toxicol. Oncol., 21, 131-139 (2002a) 

  24. Chun, K.-S., Keum, Y.-S., Han, S.-S., Song, Y.-S., Kim, S.-H., and Surh, Y.-J., Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF- ${\kappa}$ B activation. Carcinogenesis, 24, 1515-1524 (2003) 

  25. Chun, K. S., Kim, S. H., Song, Y. S., and Surh, Y. J., Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis, 25, 713-722 (2004) 

  26. Chun, K.-S., Park, K.-K., Lee, J., Kang, M., and Surh, Y.-J., Inhibition of mouse skin tumor promotion by antiinflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae). Oncol. Res., 13, 37-45 (2002b) 

  27. Chun, K.-S. and Surh, Y.-J., Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol., 68, 1089-1100 (2004) 

  28. Clevers, H., At the crossroads of inflammation and cancer. Cell, 118, 671-674 (2004) 

  29. Conney, A. H., Lou, Y. R., Xie, J. G., Osawa, T., Newmark, H. L., Liu, Y., Chang, R. L., and Huang, M. T., Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc. Soc. Exp. Biol. Med., 216, 234-245 (1997) 

  30. Cui, Y., Kim, D. S., Park, S. H., Yoon, J. A., Kim, S. K., Kwon, S. B., and Park, K. C., Involvement of ERK and p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells. Chem. Phys. Lipids, 129, 43-52 (2004) 

  31. D'Acquisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di Rosa, M. and Carnuccio, R., Involvement of NF- ${\kappa}$ B in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett., 418, 175-178 (1997) 

  32. Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., and Subbaramaiah, K., Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2, 544-551 (2001) 

  33. Deak, M., Clifton, A. D., Lucocq, L. M., and Alessi, D. R., Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J., 17, 4426-4441 (1998) 

  34. Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougere, M., Henry, E., Galteau, M. M., Dicato, M., and Diederich, M., Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor ${\kappa}$ B inhibition. Biochem. Pharmacol., 68, 1101-1111 (2004) 

  35. Evans, J. F., Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer. Am. J. Clin. Oncol., 26, S62-65 (2003) 

  36. Fischer, S. M., Lo, H. H., Gordon, G. B., Seibert, K., Kelloff, G., Lubet, R. A., and Conti, C. J., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 25, 231-240 (1999) 

  37. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U.S.A., 94, 2927- 2932 (1997) 

  38. Ghosh, S. and Karin, M., Missing pieces in the NF- ${\kappa}$ B puzzle. Cell, 109, S81-S96 (2002) 

  39. Giardiello, F. M., Offerhaus, G. J., and DuBois, R. N., The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A, 1071-1076 (1995) 

  40. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E., Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333, 609-614 (1995) 

  41. Gorgoni, B., Caivano, M., Arizmendi, C., and Poli, V., The transcription factor C/EBP ${\beta}$ is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem., 276, 40769-40777 (2001) 

  42. Greenberg, E. R., Baron, J. A., Freeman, D. H., Jr., Mandel, J. S., and Haile, R., Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J. Natl. Cancer Inst., 85, 912-916 (1993) 

  43. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F., and Karin, M., IKK ${\beta}$ links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell, 118, 285-296 (2004) 

  44. Grubbs, C. J., Lubet, R. A., Koki, A. T., Leahy, K. M., Masferrer, J. L., Steele, V. E., Kelloff, G. J., Hill, D. L., and Seibert, K., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamineinduced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res., 60, 5599-5602 (2000) 

  45. Guan, Z., Buckman, S. Y., Miller, B. W., Springer, L. D., and Morrison, A. R., Interleukin-1 $\beta$ -induced cyclooxygenase-2 expression requires activation of both c-Jun $NH_2$ -terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem., 273, 28670-28676 (1998) 

  46. Han, S.-S., Keum, Y.-S., Seo, H.-J., Chun, K.-S., Lee, S.-S., and Surh, Y.-J., Capsaicin suppresses phorbol ester-induced activation of NF- ${\kappa}$ B/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett., 164, 119-126 (2001) 

  47. Harnish, D. C., Scicchitano, M. S., Adelman, S. J., Lyttle, C. R., and Karathanasis, S. K., The role of CBP in estrogen receptor cross-talk with nuclear factor- ${\kappa}$ B in HepG2 cells. Endocrinology, 141, 3403-3411 (2000) 

  48. Harris, R. E., Alshafie, G. A., Abou-Issa, H., and Seibert, K., Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res., 60, 2101-2103 (2000) 

  49. Huang, M. T., Newmark, H. L., and Frenkel, K., Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl., 27, 26-34 (1997) 

  50. Huang, W. C., Chen, J. J., Inoue, H., and Chen, C. C., Tyrosine phosphorylation of I ${\kappa}$ B kinase ${\alpha}$ / ${\beta}$ by protein kinase Cdependent c-Src activation is involved in TNF- ${\alpha}$ -induced cyclooxygenase-2 expression. J. Immunol., 170, 4767-4775 (2003) 

  51. Hussain, T., Gupta, S., Adhami, V. M., and Mukhtar, H., Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer, 113, 660-669 (2005) 

  52. Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., and Peyron, J. F., Tyrosine phosphorylation of I ${\kappa}$ B- ${\alpha}$ activates NF- ${\kappa}$ B without proteolytic degradation of I ${\kappa}$ B- ${\alpha}$ . Cell, 86, 787-798 (1996) 

  53. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T., Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem., 270, 24965-24971 (1995) 

  54. Itzkowitz, S. H. and Yio, X., Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7-17 (2004) 

  55. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220 (1997) 

  56. Kang, G., Kong, P. J., Yuh, Y. J., Lim, S. Y., Yim, S. V., Chun, W., and Kim, S. S., Curcumin suppresses lipopolysaccharideinduced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor ${\kappa}$ B bindings in BV2 microglial cells. J. Pharmacol. Sci., 94, 325-328 (2004) 

  57. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412 (1998) 

  58. Keum, Y.-S., Han, S.-S., Chun, K.-S., Park, K.-K., Park, J.-H., Lee, S.-K., and Surh, Y.-J., Inhibitory effects of the ginsenoside $Rg_3$ on phorbol ester-induced cyclooxygenase- 2 expression, NF- ${\kappa}$ B activation and tumor promotion. Mutat. Res., 523-524, 75-85 (2003) 

  59. Kikuchi, T., Itoh, F., Toyota, M., Suzuki, H., Yamamoto, H., Fujita, M., Hosokawa, M., and Imai, K., Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int. J. Cancer, 97, 272-277 (2002) 

  60. Kim, C. S., Kawada, T., Kim, B. S., Han, I. S., Choe, S. Y., Kurata, T., and Yu, R., Capsaicin exhibits anti-inflammatory property by inhibiting $I{\kappa}B{\alpha}$ degradation in LPS-stimulated peritoneal macrophages. Cell Signal., 15, 299-306 (2003) 

  61. Kim, S.O., Chun, K.-S., Kundu, J., and Surh, Y.-J., Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF- ${\kappa}$ B and p38 MAPK in mouse skin. Biofactors, 21, 27-31 (2004) 

  62. Kim, S. O., Kundu, J. K., Shin, Y., Park, J.-H., Cho, M.-H., Kim, T.-Y., and Surh, Y.-J., [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF- ${\kappa}$ B in phorbol ester-stimulated mouse skin. Oncogene, in press (2005) 

  63. Kojima, M., Morisaki, T., Izuhara, K., Uchiyama, A., Matsunari, Y., Katano, M., and Tanaka, M., Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor- ${\kappa}$ B activation. Oncogene, 19, 1225- 1231 (2000) 

  64. Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P., and Giaccia, A. J., Hypoxic activation of nuclear factor- ${\kappa}$ B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res., 54, 5273-5279 (1994) 

  65. Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E., and Tanabe, T., Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem., 221, 889-897 (1994) 

  66. Kundu, J. K., Chun, K.-S., Kim, S. O., and Surh, Y.-J., Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors, 21, 33-39 (2004) 

  67. Kundu, J. K., Na, H.-K., Chun, K.-S., Kim, Y.-K., Lee, S. J., Lee, S. S., Lee, O.-S., Sim, Y.-C., and Surh, Y.-J., Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr., 133, 3805S-3810S (2003) 

  68. Kundu, J. K. and Surh, Y.-J., Molecular basis of chemoprevention by resveratrol: NF- ${\kappa}$ B and AP-1 as potential targets. Mutat. Res., 555, 65-80 (2004) 

  69. Leahy, K. M., Ornberg, R. L., Wang, Y., Zweifel, B. S., Koki, A. T., and Masferrer, J. L., Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res., 62, 625-631 (2002) 

  70. Lee, J.-Y., Shin, J.-W., Chun, K.-S., Park, K. K., Chung, W.-Y., Bang, Y.-J., Sung, J.-H., and Surh, Y.-J., Anti-tumor promotional effects of a novel intestinal bacterial metabolite (IH- 901) derived from the protopanaxadiol type ginsenosides in mouse skin. Carcinogenesis, in press 

  71. Leung, W. K., To, K. F., Ng, Y. P., Lee, T. L., Lau, J. Y., Chan, F. K., Ng, E. K., Chung, S. C., and Sung, J. J., Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br. J. Cancer, 84, 335-339 (2001) 

  72. Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., and Kurzrock, R., Nuclear factor- ${\kappa}$ B and I ${\kappa}$ B kinase are constitutively active in human pancreatic cells, and their downregulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer, 101, 2351-2362 (2004) 

  73. Li, Z. G., Shimada, Y., Sato, F., Maeda, M., Itami, A., Kaganoi, J., Komoto, I., Kawabe, A., and Imamura, M., Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamineinduced esophageal tumorigenesis in F344 rats. Int. J. Oncol., 21, 1275-1283 (2002) 

  74. Liu, S. F., Ye, X., and Malik, A. B., Inhibition of NF- ${\kappa}$ B activation by pyrrolidine dithiocarbamate prevents in vivo expression of pro-inflammatory genes. Circulation, 100, 1330-1337 (1999) 

  75. Liu, W., Reinmuth, N., Stoeltzing, O., Parikh, A. A., Tellez, C., Williams, S., Jung, Y. D., Fan, F., Takeda, A., Akagi, M., Bar- Eli, M., Gallick, G. E., and Ellis, L. M., Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res., 63, 3632-3636 (2003) 

  76. Madrid, L. V., Mayo, M. W., Reuther, J. Y., and Baldwin, A. S., Jr., Akt stimulates the transactivation potential of the RelA/ p65 Subunit of NF- ${\kappa}$ B through utilization of the I ${\kappa}$ B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem., 276, 18934-18940 (2001) 

  77. Marks, F., Muller-Decker, K., and Furstenberger, G., A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology, 153, 11-26 (2000) 

  78. Martin, A. R., Villegas, I., La Casa, C., and de la Lastra, C. A., Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol., 67, 1399- 1410 (2004) 

  79. Martinez, J. and Moreno, J. J., Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol., 59, 865-870 (2000) 

  80. Marx, J., Cancer research. Inflammation and cancer: the link grows stronger. Science, 306, 966-968 (2004) 

  81. Miller, C., Zhang, M., He, Y., Zhao, J., Pelletier, J. P., Martel- Pelletier, J., and Di Battista, J. A., Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J. Cell. Biochem., 69, 392-413 (1998) 

  82. Molina-Holgado, E., Ortiz, S., Molina-Holgado, F., and Guaza, C., Induction of COX-2 and $PGE_{2}$ biosynthesis by IL-1 ${\beta}$ is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol., 131, 152-159 (2000) 

  83. Muller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., and Furstenberger, G., Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA, 99, 12483-12488 (2002) 

  84. Murakami, A., Matsumoto, K., Koshimizu, K., and Ohigashi, H., Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferongamma- induced I ${\kappa}$ B degradation in RAW264.7 macrophages. Cancer Lett., 195, 17-25 (2003) 

  85. Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Brautigam, L., Grosch, S., and Geisslinger, G., Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF- ${\kappa}$ B. FASEB J., 15, 1622-1624 (2001) 

  86. Nugent, K. P., Farmer, K. C., Spigelman, A. D., Williams, C. B., and Phillips, R. K., Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br. J. Surg., 80, 1618-1619 (1993) 

  87. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M., Suppression of intestinal polyposis in Apc $^{\delta716}$ knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809 (1996) 

  88. Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M. M., and Evans, J. F., Chemoprevention of intestinal polyposis in the $Apc^{\delta716}$ mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res., 61, 1733- 1740 (2001) 

  89. Park, J. W., Choi, Y. J., Suh, S. I., and Kwon, T. K., Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells. Biochem. Biophys. Res. Commun., 286, 721-725 (2001) 

  90. Park, K. K., Chun, K.-S., Lee, J.-M., Lee, S. S., and Surh, Y.-J., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett., 129, 139-144 (1998) 

  91. Park, K. K., Chun, K.-S., Yook, J. I., and Surh, Y.-J., Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis. Anticancer Res., 18, 4201-4205 (1998) 

  92. Park, K. K. and Surh, Y.-J., Effects of capsaicin on chemicallyinduced two-stage mouse skin carcinogenesis. Cancer Lett., 114, 183-184 (1997) 

  93. Park, O.-J. and Surh, Y.-J., Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol. Lett., 150, 43-56 (2004) 

  94. Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N., and Han, R., Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis, 20, 1939-1944 (1999) 

  95. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y., NF- ${\kappa}$ B functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-466 (2004) 

  96. Qiao, L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., and Rigas, B., Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258, 215-223 (1995) 

  97. Rigas, B., Goldman, I. S., and Levine, L., Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518- 523 (1993) 

  98. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W., I ${\kappa}$ B kinases phosphorylate NF- ${\kappa}$ B p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem., 274, 30353- 30356 (1999) 

  99. Schreinemachers, D. M. and Everson, R. B., Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5, 138-146 (1994) 

  100. Shao, J., Sheng, H., Inoue, H., Morrow, J. D., and DuBois, R. N., Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275, 33951-33956 (2000) 

  101. Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., and Beauchamp, R. D., Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem., 275, 6628-6635 (2000) 

  102. Sheng, H., Shao, J., and Dubois, R. N., K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res., 61, 2670- 2675 (2001) 

  103. Sheng, H., Williams, C. S., Shao, J., Liang, P., DuBois, R. N., and Beauchamp, R. D., Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem., 273, 22120-22127 (1998) 

  104. Shishodia, S. and Aggarwal, B. B., Nuclear factor- ${\kappa}$ B: a friend or a foe in cancer? Biochem. Pharmacol., 68, 1071-1080 (2004) 

  105. Shishodia, S., Koul, D., and Aggarwal, B. B., Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF- ${\kappa}$ B activation through inhibition of activation of I ${\kappa}$ B ${\alpha}$ kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J. Immunol., 173, 2011- 2022 (2004) 

  106. Shishodia, S., Potdar, P., Gairola, C. G., and Aggarwal, B. B., Curcumin (diferuloylmethane) down-regulates cigarette smokeinduced NF- ${\kappa}$ B activation through inhibition of I ${\kappa}$ B ${\alpha}$ kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis, 24, 1269- 1279 (2003) 

  107. Sizemore, N., Leung, S., and Stark, G. R., Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF- ${\kappa}$ B p65/ RelA subunit. Mol. Cell Biol., 19, 4798-4805 (1999) 

  108. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B., The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342, 1946-1952 (2000) 

  109. St-Germain, M. E., Gagnon, V., Mathieu, I., Parent, S., and Asselin, E., Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int. J. Oncol., 24, 1311-1324 (2004a) 

  110. St-Germain, M. E., Gagnon, V., Parent, S., and Asselin, E., Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF- ${\kappa}$ B/I ${\kappa}$ B pathway. Mol. Cancer., 3, 7 (2004b) 

  111. Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., and Dannenberg, A. J., Inhibition of cyclooxygenase- 2 gene expression by p53. J. Biol. Chem., 274, 10911-10915 (1999) 

  112. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273, 21875-21882 (1998) 

  113. Subbaramaiah, K., Norton, L., Gerald, W., and Dannenberg, A. J., Cyclooxygenase-2 is overexpressed in HER-2/neupositive breast cancer: evidence for involvement of AP-1 and PEA3. J. Biol. Chem., 277, 18649-18657 (2002) 

  114. Subbaramaiah, K., Zakim, D., Weksler, B. B., and Dannenberg, A. J., Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 201-210 (1997) 

  115. Surh, Y.-J., Cancer chemoprevention with dietary phytochemicals. Nature Rev. Cancer, 3, 768-780 (2003) 

  116. Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S.-S., Keum, Y.-S., Park, K.-K., and Lee, S.-S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- ${\kappa}$ B activation. Mutat. Res., 480-481, 243- 268 (2001) 

  117. Surh, Y.-J., Han, S.-S., Keum, Y.-S., Seo, H.-J., and Lee, S.-S., Inhibitory effects of curcumin and capsaicin on phorbol esterinduced activation of eukaryotic transcription factors, NF- ${\kappa}$ B and AP-1. Biofactors, 12, 107-112 (2000) 

  118. Surh, Y.-J., Lee, R. C., Park, K.-K., Mayne, S. T., Liem, A., and Miller, J. A., Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis, 16, 2467-2471 (1995) 

  119. Surh, Y.-J. and Lee, S.-S., Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci., 56, 1845-1855 (1995) 

  120. Surh, Y.-J. and Lee, S.-S., Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem. Toxicol., 34, 313-316 (1996) 

  121. Surh, Y.-J., Na, H.-K., and Lee, S.-S., Transcription factors and mitogen-activated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals. Biofactors, 21, 103-108 (2004) 

  122. Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., and Aggarwal, B. B., Hydrogen peroxide activates NF- ${\kappa}$ B through tyrosine phosphorylation of I ${\kappa}$ B ${\alpha}$ and serine phosphorylation of p65: evidence for the involvement of IkBa kinase and Syk protein-tyrosine kinase. J. Biol. Chem., 278, 24233-24241 (2003) 

  123. Takahashi, N., Tetsuka, T., Uranishi, H., and Okamoto, T., Inhibition of the NF- ${\kappa}$ B transcriptional activity by protein kinase A. Eur. J. Biochem., 269, 4559-4565 (2002) 

  124. Takeda, K., Kanekura, T., and Kanzaki, T., Negative feedback regulation of phosphatidylinositol 3-kinase/Akt pathway by over-expressed cyclooxygenase-2 in human epidermal cancer cells. J. Dermatol., 31, 516-523 (2004) 

  125. Tang, Q., Gonzales, M., Inoue, H., and Bowden, G. T., Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res., 61, 4329-4332 (2001) 

  126. Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J., Sessoms, A., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., and Langenbach, R., Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62, 3395-3401 (2002) 

  127. Tjandrawinata, R. R. and Hughes-Fulford, M., Up-regulation of cyclooxygenase-2 by product-prostaglandin $E_2$ . Adv. Exp. Med. Biol., 407, 163-170 (1997) 

  128. Tsujii, M. and DuBois, R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501 (1995) 

  129. van Rees, B. P., Saukkonen, K., Ristimaki, A., Polkowski, W., Tytgat, G. N., Drillenburg, P., and Offerhaus, G. J., Cyclooxygenase- 2 expression during carcinogenesis in the human stomach. J. Pathol., 196, 171-179 (2002) 

  130. Vanderveen, E. E., Grekin, R. C., Swanson, N. A., and Kragballe, K., Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch. Dermatol., 122, 407-412 (1986) 

  131. Verma, A. K., Ashendel, C. L., and Boutwell, R. K., Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-Otetradecanoylphorbol- 13-acetate. Cancer Res., 40, 308-315 (1980) 

  132. Wang, D. and Baldwin, A. S., Jr., Activation of nuclear factorkappaB- dependent transcription by tumor necrosis factoralpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem., 273, 29411-29416 (1998) 

  133. Wang, H. Q., Kim, M. P., Tiano, H. F., Langenbach, R., and Smart, R. C., Protein kinase C-alpha coordinately regulates cytosolic phospholipase $A_{2}$ activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. Mol. Pharmacol., 59, 860-866 (2001) 

  134. Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J., The cellular response to oxidative stress: influences of mitogenactivated protein kinase signalling pathways on cell survival. Biochem. J., 333 ( Pt 2), 291-300 (1998) 

  135. Wesselborg, S., Bauer, M. K., Vogt, M., Schmitz, M. L., and Schulze-Osthoff, K., Activation of transcription factor NF- ${\kappa}$ B and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem., 272, 12422-12429 (1997) 

  136. Wilgus, T. A., Koki, A. T., Zweifel, B. S., Kusewitt, D. F., Rubal, P. A., and Oberyszyn, T. M., Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol. Carcinog., 38, 49-58 (2003) 

  137. Wong, B. C., Jiang, X., Fan, X. M., Lin, M. C., Jiang, S. H., Lam, S. K., and Kung, H. F., Suppression of RelA/p65 nuclear translocation independent of I ${\kappa}$ B- ${\alpha}$ degradation by cyclooxygenase- 2 inhibitor in gastric cancer. Oncogene, 22, 1189- 1197 (2003) 

  138. Wu, K. K., Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin. Vasc. Med., 3, 107-112 (2003) 

  139. Xie, W. and Herschman, H. R., v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun Nterminal kinase and the c-Jun transcription factor. J. Biol. Chem., 270, 27622-27628 (1995) 

  140. Yan, X., Wu Xiao, C., Sun, M., Tsang, B. K., and Gibb, W., Nuclear factor ${\kappa}$ B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1 ${\beta}$ . Biol. Reprod., 66, 1667-1671 (2002) 

  141. Yang, F., Tang, E., Guan, K., and Wang, C. Y., IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol., 170, 5630-5635 (2003) 

  142. Yip-Schneider, M. T., Barnard, D. S., Billings, S. D., Cheng, L., Heilman, D. K., Lin, A., Marshall, S. J., Crowell, P. L., Marshall, M. S., and Sweeney, C. J., Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis, 21, 139-146 (2000) 

  143. Yucel-Lindberg, T., Ahola, H., Carlstedt-Duke, J., and Modeer, T., Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin $E_2$ production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. Biochem. Biophys. Res. Commun., 257, 528-532 (1999) 

  144. Zhong, H., Voll, R. E., and Ghosh, S., Phosphorylation of NF- ${\kappa}$ B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell, 1, 661-671 (1998) 

  145. Zhou, W., Jiang, Z. W., Tian, J., Jiang, J., Li, N., and Li, J. S., Role of NF- ${\kappa}$ B and cytokine in experimental cancer cachexia. World. J. Gastroenterol., 9, 1567-1570 (2003) 

  146. Zweifel, B. S., Davis, T. W., Ornberg, R. L., and Masferrer, J. L., Direct evidence for a role of cyclooxygenase 2-derived prostaglandin $E_2$ in human head and neck xenograft tumors. Cancer Res., 62, 6706-6711 (2002) 

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트